Combination phentermine and topiramate for weight maintenance: the first Australian experience
暂无分享,去创建一个
J. Proietto | P. Sumithran | C. Houlihan | C. Haywood | S. Neoh | Fiona T H Lee | Christine A. Houlihan
[1] F. Greenway,et al. Addiction potential of phentermine prescribed during long-term treatment of obesity , 2014, International Journal of Obesity.
[2] A. Shulkes,et al. Ketosis and appetite-mediating nutrients and hormones after weight loss , 2013, European Journal of Clinical Nutrition.
[3] E. Banks,et al. Inequalities in bariatric surgery in Australia: findings from 49 364 obese participants in a prospective cohort study , 2012, The Medical journal of Australia.
[4] F. Greenway,et al. Blood Pressure and Heart Rate Effects, Weight Loss and Maintenance During Long‐Term Phentermine Pharmacotherapy for Obesity , 2011, Obesity.
[5] K. Gadde,et al. Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) , 2011, Obesity.
[6] A. Shulkes,et al. Long-term persistence of hormonal adaptations to weight loss. , 2011, The New England journal of medicine.
[7] G. Bray,et al. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. , 2003, Obesity research.
[8] A. Powell. Two-year sustained weight loss and metabolic benefits with controlled-release Phentermine/Topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study , 2012 .